Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Procrea Holdings Inc. (7384:JPX), powered by AI.
Procrea Holdings Inc. is currently trading at ¥3,610. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Procrea Holdings Inc. on Alpha Lenz.
Procrea Holdings Inc.'s P/E ratio is 83.6.
“Procrea Holdings Inc. trades at a P/E of 83.6 (premium valuation) with modest ROE of 0.8%.”
Ask for details →Procrea Holdings Inc. is a diversified company primarily engaged in the development and management of healthcare facilities and services. With a sharp focus on enhancing the quality of healthcare, Procrea Holdings Inc. oversees a broad spectrum of operations, from hospitals and diagnostic centers to specialized clinics and wellness centers. This extensive network enables the company to cater to both individual patient needs and larger institutional healthcare demands. A significant player in the healthcare industry, Procrea Holdings Inc. is instrumental in introducing innovative healthcare solutions and technologies, enhancing patient care efficiency and service delivery. The company's market significance is underscored by its continuous commitment to expanding healthcare accessibility and improving patient outcomes, a mission that resonates across the global health sector. Through strategic alliances and investment in state-of-the-art facilities, Procrea Holdings Inc. maintains a pivotal role in driving transformation within the healthcare infrastructure.
“Procrea Holdings Inc. trades at a P/E of 83.6 (premium valuation) with modest ROE of 0.8%.”
Ask for details →Procrea Holdings Inc. (ticker: 7384) is a company listed on JPX in the Financial Services sector (Banks - Regional). It has approximately 2,355 employees. Market cap is $102.6B.
The current price is 3,610 with a P/E ratio of 83.58x and P/B of 0.65x.
ROE is 0.75%. Annual revenue is $73.8B.